A Randomized, Single Site, Double Blind, Fixed Dose, Cross Over Study of Viokase16, Viokase16 Plus Nexium and Nexium Alone in the Reduction of Abdominal Pain in Patients With Chronic Pancreatitis A Randomized, Single Site, Double Blind, Fixed Dose, Cross Over Study of Viokase16, Viokase16 Plus ...
Chronic Pancreatitis
Drug: Nexium (esomeprazole magnesium);Drug: Placebo to Nexium;Drug: Viokase16 (pancrelipase) + Nexium;Drug: Viokase16 + placebo to Nexium Drug: Nexium (esomeprazole magnesium);Drug: Placebo to Nexium;Drug: Viokase16(pancrelipase) + Nexiu ...
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE ...
An Open-Label Cross-over Study to Evaluate the Intraduodenal Delivery of Lipase, Protease and Amylase From Administration of VIOKASE16 in Chronic Pancreatitis Subjects With Exocrine Pancreatic Insufficiency (EPI). An Open-Label Cross-over Study to Evaluate the Intraduodenal Delivery of Lipase, Protease and Amylas ...
Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of Viokase® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic Insufficiency A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the ...